364 related articles for article (PubMed ID: 24392945)
1. Comparative studies for ciprofloxacin hydrochloride pre-formed gels and thermally triggered (in situ) gels: in vitro and in vivo appraisal using a bacterial keratitis model in rabbits.
Abdelkader H; Mansour HF
Pharm Dev Technol; 2015 Jun; 20(4):410-6. PubMed ID: 24392945
[TBL] [Abstract][Full Text] [Related]
2. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
Mansour M; Mansour S; Mortada ND; Abd Elhady SS
Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmic delivery of sparfloxacin from in situ gel formulation for treatment of experimentally induced bacterial keratitis.
Nesseem DI
Drug Test Anal; 2011 Feb; 3(2):106-15. PubMed ID: 21322120
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
5. Hybrid thermosensitive-mucoadhesive
Fathalla Z; Mustafa WW; Abdelkader H; Moharram H; Sabry AM; Alany RG
Drug Deliv; 2022 Dec; 29(1):374-385. PubMed ID: 35068268
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
Khan N; Aqil M; Imam SS; Ali A
Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
[TBL] [Abstract][Full Text] [Related]
8. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
[TBL] [Abstract][Full Text] [Related]
9. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits.
Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH
Int J Pharm; 2013 Feb; 443(1-2):293-305. PubMed ID: 23333217
[TBL] [Abstract][Full Text] [Related]
10. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
11. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
Mannis MJ
Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
[TBL] [Abstract][Full Text] [Related]
12. Formulation of Ocular In Situ Gels with Lithuanian Royal Jelly and Their Biopharmaceutical Evaluation In Vitro.
Perminaite K; Marksa M; Stančiauskaitė M; Juknius T; Grigonis A; Ramanauskiene K
Molecules; 2021 Jun; 26(12):. PubMed ID: 34200887
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
Callegan MC; Engel LS; Hill JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic effects of WP-0405, a thermo-setting ofloxacin gel, on methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Fukaya Y; Kurita A; Tsuruga H; Naito A; Nakaya S; Sato M; Kamata Y; Hirata H; Kambara Y; Kurasawa N; Wada T; Toyoda Y; Shirasawa E; Ohashi Y
J Ocul Pharmacol Ther; 2006 Aug; 22(4):258-66. PubMed ID: 16910867
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lenses.
Hui A; Willcox M; Jones L
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4896-904. PubMed ID: 25028363
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
[TBL] [Abstract][Full Text] [Related]
17. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental bacterial keratitis with topical trovafloxacin.
Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
[TBL] [Abstract][Full Text] [Related]
19. Effect of salts on gelation and drug release profiles of methylcellulose-based ophthalmic thermo-reversible in situ gels.
Bhowmik M; Bain MK; Ghosh LK; Chattopadhyay D
Pharm Dev Technol; 2011 Aug; 16(4):385-91. PubMed ID: 20429816
[TBL] [Abstract][Full Text] [Related]
20. Eye drops and eye gels of levofloxacin: comparison of ocular absorption characterizations and therapeutic effects in the treatment of bacterial keratitis in rabbits.
Li G; Xu L; Jiang M; Wu X
Drug Dev Ind Pharm; 2020 Apr; 46(4):673-681. PubMed ID: 32233932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
